Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy Vs Physiotherapy Alone for Spastic Diplegia

Spastic Diplegia Clinical Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00004751
• Other study ID #: 199/11667
• Secondary ID: CHS-01699211
• Status: Active, not recruiting
• Phase: Phase 2
• First received: February 24, 2000
• Last updated: June 23, 2005
• Start date: October 1991

Study information

• Verified date: February 1997
• Source: Office of Rare Diseases (ORD)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

OBJECTIVES:

I. Assess the efficacy and safety of selective dorsal rhizotomy and physiotherapy compared with physiotherapy alone in improving gross motor function and reducing spasticity in children with spastic diplegia.

Description:

PROTOCOL OUTLINE: This is a randomized study. Patients are stratified by age and the ability to ambulate 50 feet unaided. Each stratum is block randomized.

Patients are randomly assigned to surgery plus intensive physical therapy versus intensive physical therapy alone.

The surgical procedure is a selective dorsal rhizotomy. Physical therapy (PT) includes passive and active range of motion, facilitation of isolated muscle control, transitional movements, strengthening, transfer skills, and gait training. The PT schedule is 2-hour sessions 5 days a week for 1 month, 1-hour sessions 5 days a week for 5 months, then a standard therapy program for the remainder of the study (total of 6 months). Parents supervise exercise on non-PT days.

Patients are followed at 6, 12, and 24 months.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 0
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 3 Years to 18 Years

Eligibility

PROTOCOL ENTRY CRITERIA:

--Disease Characteristics--

• Spastic diplegia, i.e.: Measurable spasticity with more lower than upper limb involvement

• Fair to good trunk and head control

• Little or no bulbar involvement

• Able to walk or has potential to walk indoors with assistive devices

• No fixed musculoskeletal deformity greater than 15 degrees

• Prior orthopedic surgery acceptable if spastic muscle group is in physiologic biomechanical position and retains voluntary power

• No detectable athetosis, rigidity, ataxia, or other movement disorder

• No disease-related, treatable condition that may become urgent during study, e.g., hip subluxation requiring adductor release

--Patient Characteristics--

• Age: 3 to 18

• Other: Intelligence Quotient greater than 50 Developmental age 3 years or higher

• Able to follow multi-step commands

• Expressive communication skills at 3-year level or higher

• Mild dysarthria or drooling does not exclude

• Stable social environment

• Regular school and physical therapy attendance

• Normal psychiatric status

• Guardian able to give support and follow-up care

• No medical contraindication to anesthesia or surgery, e.g.: Previous anesthesia reaction

• Chronic lung disease

• Uncontrollable seizures

• Scoliosis Vertebral anomaly

• Neural tube defect

• No visual impairment sufficient to hinder mobility

• Able to come to Children's Hospital and Medical Center for follow-up Insurance coverage adequate for surgery and postoperative physiotherapy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Cerebral Palsy
• Muscle Spasticity
• Spastic Diplegia

Intervention

Procedure:
• Surgery

• Physical therapy

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
National Institute of Neurological Disorders and Stroke (NINDS)	Seattle Children's Hospital